Skip to main content

Advertisement

ADVERTISEMENT

Department

Conference Insider
11/20/2019
Statin use is associated with a 43% lower risk of hepatocellular carcinoma (HCC), according to new study results presented at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting and Postgraduate Course.
Statin use is associated with a 43% lower risk of hepatocellular carcinoma (HCC), according to new study results presented at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting and Postgraduate Course.
Statin use is associated with a...
11/20/2019
First Report Managed Care
Conference Insider
11/20/2019
AK002—an anti-SIGLEC8 antibody—may be a safe and effective treatment option in eosinophilic gastritis (EG) and eosinophilic gastroenteritis (EGE), according to results of ENIGMA, a phase 2 clinical trial.
AK002—an anti-SIGLEC8 antibody—may be a safe and effective treatment option in eosinophilic gastritis (EG) and eosinophilic gastroenteritis (EGE), according to results of ENIGMA, a phase 2 clinical trial.
AK002—an anti-SIGLEC8...
11/20/2019
First Report Managed Care
Conference Insider
11/20/2019
Gastroenterology patients with avoidant/restrictive food intake disorder (ARFID) are less likely to be taking psychotropic medications, have less-severe body image concerns, and are frustrated with being unable to eat what they want compared...
Gastroenterology patients with avoidant/restrictive food intake disorder (ARFID) are less likely to be taking psychotropic medications, have less-severe body image concerns, and are frustrated with being unable to eat what they want compared...
Gastroenterology patients with...
11/20/2019
First Report Managed Care

Advertisement

Conference Insider
11/20/2019
Budesonide oral suspension (BOS) appears to be a safe and effective induction therapy for eosinophilic esophagitis (EoE) among adolescents and adults, according to results of a phase 3 clinical trial that were presented at the ACG 2019 Annual...
Budesonide oral suspension (BOS) appears to be a safe and effective induction therapy for eosinophilic esophagitis (EoE) among adolescents and adults, according to results of a phase 3 clinical trial that were presented at the ACG 2019 Annual...
Budesonide oral suspension (BOS)...
11/20/2019
First Report Managed Care
Conference Insider
11/20/2019
Using a fluoroscopy system enabled with artificial intelligence (AI) during image-guided endoscopy can significantly reduce patients’ exposure to radiation and diminish the scatter effect to endoscopy personnel, according to late-breaking...
Using a fluoroscopy system enabled with artificial intelligence (AI) during image-guided endoscopy can significantly reduce patients’ exposure to radiation and diminish the scatter effect to endoscopy personnel, according to late-breaking...
Using a fluoroscopy system...
11/20/2019
First Report Managed Care
Conference Insider
11/20/2019
Nancy Myers, PhD, vice president at the American Hospital Association Center for Health Innovation, and James Dom Dera, MD, FAAFP, population health medical director at NewHealth Collaborative/Summa Health, discussed care coordination in the...
Nancy Myers, PhD, vice president at the American Hospital Association Center for Health Innovation, and James Dom Dera, MD, FAAFP, population health medical director at NewHealth Collaborative/Summa Health, discussed care coordination in the...
Nancy Myers, PhD, vice president...
11/20/2019
First Report Managed Care

Advertisement

Conference Insider
11/20/2019
In a session at Health Care Quality Congress 2019, David Asch, MD, MBA, of The Perelman School & Wharton School of the University of Pennsylvania, discussed how patterns of behavior can be used to improve outcomes and health care quality.
In a session at Health Care Quality Congress 2019, David Asch, MD, MBA, of The Perelman School & Wharton School of the University of Pennsylvania, discussed how patterns of behavior can be used to improve outcomes and health care quality.
In a session at Health Care...
11/20/2019
First Report Managed Care
Conference Insider
11/20/2019
In a poster presentation at AMCP Nexus 2019, researchers presented findings from two surveys examining how value assessment frameworks (VAFs) are impacting payer coverage decisions in the United States.
In a poster presentation at AMCP Nexus 2019, researchers presented findings from two surveys examining how value assessment frameworks (VAFs) are impacting payer coverage decisions in the United States.
In a poster presentation at AMCP...
11/20/2019
First Report Managed Care
Conference Insider
11/20/2019
According to data on drug pricing presented in a poster session at AMCP Nexus 2019, despite discounts and rebates, list and net prices are still increasing rapidly. Using data from the investment firm, SSR Health, researchers from the...
According to data on drug pricing presented in a poster session at AMCP Nexus 2019, despite discounts and rebates, list and net prices are still increasing rapidly. Using data from the investment firm, SSR Health, researchers from the...
According to data on drug...
11/20/2019
First Report Managed Care

Advertisement

Conference Insider
11/20/2019
When compared to prostaglandin analogs (PGA), latanoprostene bunod appears to be cost-saving in the treatment of primary open-angle glaucoma, according to data presented at AMCP Nexus 2019. 
When compared to prostaglandin analogs (PGA), latanoprostene bunod appears to be cost-saving in the treatment of primary open-angle glaucoma, according to data presented at AMCP Nexus 2019. 
When compared to prostaglandin...
11/20/2019
First Report Managed Care

Advertisement